Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24, 591-608
López-Pousa S, Garre-Olmo J, Turon-Estrada A, Hernández F, Expósito I, Lozano-Gallego M, Hernández-Ferrándiz M, Gelada-Batlle E, Pericot-Nierga I, Vilalta-Franch J
Análisis de los costes de la enfermedad de Alzheimer en función del deterioro cognitivo y funcional.
Garre-Olmo J, López-Pousa S, Vilalta-Franch J, Turon-Estrada A, Lozano-Gallego M, Hernández-Ferràndiz M, Gelada-Batlle E, Cruz-Reina MM, Morante-Muñoz V, Peralta-Rodríguez J
Neuropsychological profile of Alzheimer's disease in women: moderate and moderately severe cognitive decline.
Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2004, 52, 414-426
Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.